C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2004
12/29/2004	WO2004113550A1 Process for producing l-glutamic acid
12/29/2004	WO2004113535A1 Synuclein mutant having anticoagulant effect
12/29/2004	WO2004113533A1 LIVER X RECEPTOR α SPLICING VARIANT PROTEIN, GENE CODING FOR THE SAME AND USE THEREOF
12/29/2004	WO2004113527A1 Gene involved in abscisic acid inactivation
12/29/2004	WO2004113510A2 Production of pantothenate using microorganisms incapable of sporulation
12/29/2004	WO2004113508A1 Production of cephalosporin intermediates in penicillium chrysogenum
12/29/2004	WO2004113507A1 Pharmaceutically compatible method for purifying intact bacterial minicells
12/29/2004	WO2004113490A2 Directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixture and bioreactor
12/29/2004	WO2004112809A1 Composition for lowering serum uric acid level
12/29/2004	WO2004112476A1 Biomaterial preservation methods
12/29/2004	WO2004099418A8 Fused protein
12/29/2004	WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor
12/29/2004	WO2004087891A8 Lactobacillus fermentum strain and uses thereof
12/29/2004	WO2004074458A3 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
12/29/2004	WO2004065556A3 Pet family of efflux proteins
12/29/2004	WO2004033664A3 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
12/29/2004	WO2003089621A8 Promoter and plasmid system for genetic engineering
12/29/2004	WO2003057146A3 Novel compositions and methods for cancer
12/29/2004	WO2003038064A8 Blakeslea trispora producing high yield of lycopene in a suitable medium in the absence of an exogenous carotenogenesis inhibitor
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491634A1 Feedback resistant acetohydroxy acid synthetase mutants
12/29/2004	EP1491633A1 Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491630A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
12/29/2004	EP1491628A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
12/29/2004	EP1491625A1 Mutated isopropylmalate isomerase
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491493A2 Nanostructure fabrication using microbial mandrel
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490498A1 Saccharomyces cerevisiae mutant
12/29/2004	EP1490497A2 Egvi endoglucanase and nucleic acids encoding the same
12/29/2004	EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004	EP1490473A1 Bacterial spores
12/29/2004	EP1490472A1 Denatured spirulina and manufacturing method thereof
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490381A1 Human gene critical to fertility
12/29/2004	EP1490099A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1325135B1 Feedback-resistant pyruvate carboxylase gene from corynebacterium
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1171103B1 Inactivated microorganisms comprising substances having pharmacological activity
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1117808B1 Transformation system in the field of filamentous fungal hosts: in chrysosporium
12/29/2004	EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
12/29/2004	EP0836649B1 Cell-free synthesis of polyketides
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004	CN1558947A Peptide synthase gene, peptide synthase and process for producing dipdptide
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558945A Fermentation with cyclic pulse-pause feeding
12/29/2004	CN1558916A Compositions and methods for generating chimeric heteromultimers
12/29/2004	CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation
12/29/2004	CN1557957A Preparation method for improving output of gentamycin
12/29/2004	CN1557956A Method for dispelling monosaccharide component from oligosaccharide
12/29/2004	CN1557949A Novel cholesterol oxidase gene and use thereof
12/29/2004	CN1557944A Method for preparing composite live bacillus biological water-purifying agent
12/29/2004	CN1557943A Bacterium culture medium and preparation method therefor
12/29/2004	CN1557942A A insecticide and its application
12/29/2004	CN1557941A Process for preparing chromium-enriched beer yeast
12/29/2004	CN1557940A Composite microbe preparation and its preparing process
12/29/2004	CN1557939A Growth factor containing cell culture solution additive
12/29/2004	CN1557406A Producing method of red rice fat reducing tea
12/29/2004	CN1557405A Preparing process of antihyperglycemic tea with functions of inhibiting cholesterol synthesization
12/29/2004	CN1557122A Schizophyllum commune artificial cultivation and breeding technology
12/29/2004	CN1182246C Mutant ilvH gene and process for producing L-valine
12/29/2004	CN1182243C Technique method for preparing nitrile hydratase by using glucose-CO2+ coupling adding ferment
12/29/2004	CN1182242C Ecological safety type nitragin preparation production process and its production method
12/29/2004	CN1182240C Barm expressing system of plasminogen and purifying process
12/29/2004	CN1182239C Spraying drying technique for preparing solid oceanic rhodotorula
12/29/2004	CN1182238C Aspergillus tamarii var.Yunnanensis Ym3221
12/29/2004	CA2530641A1 Directed selective solid-phase culturing of stable microbial mixed populations for the continuous preparation of defined enzyme and metabolite mixture and bioreactor
12/29/2004	CA2529288A1 Composition for lowering serum uric acid level
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/28/2004	US6835821 Useful mutations of bacterial alkaline protease
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835815 Nod2 nucleic acids and proteins
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835569 Amino polyol oxidase amine polynucleotides and related polypeptides and methods of use
12/28/2004	US6835568 Regulated nucleic acid expression system
12/28/2004	US6835561 Composition of reverse transcriptases and mutants thereof
12/28/2004	US6835556 Protein cluster V
12/28/2004	US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/28/2004	US6835548 Isoforms of mouse serotonin 5-HT2c receptor
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835539 Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications
12/28/2004	US6835384 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
12/28/2004	US6835376 Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/23/2004	WO2004111257A1 Method for the microbiological isomerisation of alpha-hydroxy carboxylic acids

1 ... 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 ... 1489